Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N07BC01	BUPRENORPHINE ARROW	G	Buprenorphine - 8mg	8mg	Tablet	1,115,389 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 8mg	8mg	Injectable solution prolonged release	8,524,771 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 96mg	96mg	Injectable solution prolonged release	34,835,645 L.L
A03BB01	BUSCOPAN	B	Butylscopolamine bromide - 10mg	10mg	Tablet, sugar coated	692,079 L.L
A03BB01	BUSCOPAN	B	Butylscopolamine bromide - 10mg	10mg	Tablet, sugar coated	291,614 L.L
D05AX52	BETA-CAL	G	Calcipotriol (monohydrate) - 50mcg/g, Betamethasone (dipropionate) - 0.5mg/g		Ointment	1,574,983 L.L
D05AX52	BETA-CAL	G	Calcipotriol (monohydrate) - 50mcg/g, Betamethasone (dipropionate) - 0.5mg/g		Gel	1,251,117 L.L
V03AF03	BENDAFOLIN	G	Calcium folinate - 200mg/20ml	200mg/20ml	Injectable solution	3,584,028 L.L
C09CA06	BLOPRESS	B	Candesartan cilexetil - 16mg	16mg	Tablet	1,131,515 L.L
C09DA06	BLOPRESS PLUS 16MG	B	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg		Tablet	1,257,837 L.L
C09CA06	BLOPRESS	B	Candesartan cilexetil - 8mg	8mg	Tablet	847,965 L.L
C09DA06	BLOPRESS PLUS 8MG	B	Candesartan cilexetil - 8mg, Hydrochlorothiazide - 12.5mg		Tablet	1,060,292 L.L
J01DB05	BIODROXIL	G	Cefadroxil (monohydrate) - 1000mg	1,000mg	Tablet, film coated	1,091,442 L.L
J01DB05	BIODROXIL	G	Cefadroxil (monohydrate) - 500mg	500mg	Capsule	496,382 L.L
J01DD08	BETIXIM 100	G	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	348,055 L.L
J01DD08	BETIXIM 100	G	Cefixime (trihydrate) - 100mg/5ml	100mg/5ml	Powder for suspension	700,142 L.L
J01DD08	BETIXIM 400	G	Cefixime (trihydrate) - 400mg	400mg	Capsule	1,026,696 L.L
D03AX	BEPANTHEN PLUS	B	Chlorhexidine HCl - 5mg/g, Dexpanthenol - 50mg/g		Cream	319,835 L.L
G01AX12	BRUMIXOL	G	Ciclopiroxolamine - 100mg	100mg	Ovule	795,555 L.L
J01MA02	BACTALL 500	G	Ciprofloxacine (HCl) - 500mg	500mg	Tablet, film coated	292,958 L.L
A03CA02	BIPAX	G	Clidinium bromide - 2.5mg, Chlordiazepoxide - 5mg		Tablet, sugar coated	363,477 L.L
M03AX01	BOTOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100U	100U	Injectable powder for solution	18,625,995 L.L
M03AX01	BOTOX	BioTech	Clostridium botulinum type A neurotoxin complex - 100U	100U	Injectable powder for solution	18,625,995 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 250IU	250IU	Injectable lyophilised powder for solution+diluent	14,098,526 L.L
B02BD02	BERIATE	BioHuman	Coagulation Factor VIII - 500IU	500IU	Injectable lyophilised powder for solution+diluent	28,437,886 L.L
J01MA23	BAXDELA	B	Delafloxacin - 300mg	300mg	Injectable concentrate for solution	78,349,010 L.L
J01MA23	BAXDELA	B	Delafloxacin - 450mg	450mg	Tablet	93,777,847 L.L
R05FB	BRONCHOPHANE	G	Dextrometorphan HBr - 4.58mg/5ml, Diphenydramine HCl - 5mg/5ml, Ephedrine HCl - 7.5mg/5ml, Guaifenesin - 50mg/5ml		Syrup	115,570 L.L
J07AJ51	BOOSTRIX	B	Diphteria toxoid purified - ≥2.5Lf/0.5ml, Tetanus toxoid purified - ≥5Lf/0.5ml, Bordetella Pertussis Antigens: toxoid - 8mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 8mcg/0.5ml, Pertactine - 2.5mcg Al3+/0.5ml, Aluminium hydroxide - 0.3mg Al3+/0.5ml, Aluminium Phosphate - 0.2mg/0.5ml		Injectable suspension	1,394,909 L.L
L01EC03	BRAFTOVI	BioTech	Encorafenib - 50mg	50mg	Capsule, hard	70,084,833 L.L